Prostate Cancer Archive

A new calculation tool that focuses on family history and specific genetic variants may help identify men at high risk for prostate cancer and help determine who would benefit most from routine screening.

Doctors used to recommend treating all men with prostate cancer; now they are likely to advise active surveillance for lower-risk cancers. But some men require closer monitoring — so how do they determine which ones?

In some men who have prostate cancer surgery the cancer never returns, while in others it does. A new type of imaging technology indicates the presence of prostate tumors, and researchers wanted to know if this could be used to predict cancer recurrence after treatment.

This year, results from a review of literature on plant-based diets and prostate cancer risk concluded that apart from having advantages for cardiovascular health, quality of life, and environmental benefits, plant-based diets have the potential to improve prostate cancer outcomes.

Hormonal therapy is a cornerstone of prostate cancer treatment, but it has burdensome side effects. Doctors and patients alike are highly motivated to use this therapy only for as long as necessary. But how long is long enough? A recent study provides needed clarity.

Over-the-counter supplements touted to support prostate health are popular, and supposedly help prevent and manage symptoms of an enlarged prostate (benign prostate hyperplasia). Some of the ingredients are said to protect against prostate cancer or slow its growth. While research has explored supplements' role in prostate health and some had positive results, the findings are far from conclusive. A better dietary option for prostate health is to follow a plant-based diet like the Mediterranean or DASH diet.

When prostate cancer spreads beyond the gland, it has been treated with hormone therapy, but there are challenging side effects. A new study shows that a different treatment option involving radiation can allow some men to delay or avoid hormone therapy.

Groundbreaking cancer treatments continuously emerge from labs and research trials. Three Harvard oncologists share what stands out in their respective fields of prostate, lung, and colon cancer, the most common cancers among men. Examples include greater roles for immunotherapy, targeted therapy, and intensive hormonal treatments.

Men with lower-risk prostate cancer often opt for active surveillance, which involves regular testing and biopsies to check for possible tumor growth. A newer type of imaging may reduce the frequency of repeat biopsies for some men, but there are concerns about its limitations.

A standard treatment for localized prostate cancer is radiation, but there is a risk that it can lead to secondary cancers forming in the body later. Now, a large study of men treated with current radiation delivery methods clarifies that the amount of risk is low, but real.